Title
Date
- MFDS IND Deficiencies: What to Check Before Submission
- MFDS Updates Digital Therapeutic Clinical Trial Guidance: What Changed for Korea Trial Design in 2026?
- MFDS’s AI Review Rollout and Medical Device Negative-List Reform: What They Actually Mean for Korea Clinical Trial Timelines in 2026
- Analysis of MFDS IND Approval Trends in June 2026
- Korea Drug Classification Rule Update 2026: What MFDS’s Partial Amendment Means for Pharma Companies
- MFDS Fast‑Track 2026: Navigating GIFT Korea, Priority Review & Conditional Approval
- Korea Clinical Trial Strategy After MFDS 2025 Reforms: Why Korea is Becoming a Strategic Hub
- 2026 MFDS IND Approval Trends and Triple‑Agonist Clinical Trial Strategies in Korea
- MFDS Drug Approval Reform 2025: Process & Timeline Updates
- 2025 Korea Drug Safety Regulation Updates: A Complete Guide for Practitioners